PLEDGE AND SECURITY AGREEMENT dated as of March 17, 2011 by and among K-V PHARMACEUTICAL COMPANY, EACH OF THE GRANTORS PARTY HERETO and WILMINGTON TRUST FSB, as Collateral AgentPledge and Security Agreement • March 23rd, 2011 • Kv Pharmaceutical Co /De/ • Pharmaceutical preparations
Contract Type FiledMarch 23rd, 2011 Company IndustryThis PLEDGE AND SECURITY AGREEMENT, dated as of March 17, 2011 (as it may be amended, restated, supplemented or otherwise modified from time to time, this “Agreement”), among K-V PHARMACEUTICAL COMPANY, a Delaware corporation (the “Company”), certain Subsidiaries of the Company party hereto from time to time, whether as an original signatory hereto or as an Additional Grantor (as herein defined) (together with the Company, each, a “Grantor,” and collectively, the “Grantors”), and WILMINGTON TRUST FSB, as collateral agent for the Secured Parties (in such capacity as collateral agent, together with its successors and permitted assigns, the “Collateral Agent”).
K-V PHARMACEUTICAL COMPANY and EACH OF THE GUARANTORS NAMED HEREIN and WILMINGTON TRUST FSB, as Trustee INDENTURE Dated as of March 17, 2011 $ 225,000,000 Principal Amount 12% Senior Secured Notes due 2015Indenture • March 23rd, 2011 • Kv Pharmaceutical Co /De/ • Pharmaceutical preparations • New York
Contract Type FiledMarch 23rd, 2011 Company Industry JurisdictionINDENTURE, dated as of March 17, 2011, between K-V Pharmaceutical Company, a Delaware corporation (the “Company”), and Wilmington Trust FSB, as trustee (the “Trustee”).
ContractSecurity Agreement • March 23rd, 2011 • Kv Pharmaceutical Co /De/ • Pharmaceutical preparations • New York
Contract Type FiledMarch 23rd, 2011 Company Industry JurisdictionTHIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE ACQUIRER
PURCHASE AGREEMENTPurchase Agreement • March 23rd, 2011 • Kv Pharmaceutical Co /De/ • Pharmaceutical preparations • New York
Contract Type FiledMarch 23rd, 2011 Company Industry JurisdictionPURCHASE AGREEMENT (the “Agreement”), dated as of March 15, 2011, by and among K-V Pharmaceutical Company, a Delaware corporation, with its principal offices at One Corporate Woods Drive, Bridgeton, Missouri 63044 (the “Company”), the Guarantors named on the signature pages hereto and the investor named on the signature pages hereto (the “Buyer”).